BeyondSpring (BYSI) vs TransCode Therapeutics (RNAZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BeyondSpring (BYSI) has outperformed TransCode Therapeutics (RNAZ) over the past year, losing 64.1% versus a loss of 85.6%. Over five years, BYSI leads with a -96.1% price change compared with -100.0% for RNAZ. TransCode Therapeutics is the larger company by market cap ($29.3 million vs $25.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BYSI | RNAZ |
|---|---|---|
| Share price | $0.61 | $1.73 |
| Market cap | $25.08M | $29.29M |
| 1-day change | -5.35% | -1.70% |
| YTD return | -60.46% | -74.23% |
| 1-year return | -64.09% | -85.60% |
| 5-year return | -96.11% | -100.00% |
| EPS (TTM) | $-0.18 | $-52.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.44 | $15.94 |
| 52-week low | $0.566 | $1.52 |
| Distance from 52-week high | -75.00% | -89.15% |
| Average volume | 855.49K | 50.80K |
| Shares outstanding | 41.12M | 16.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BYSI has outperformed RNAZ by 21.5 percentage points over the past year.
BYSI vs RNAZ FAQ
Which is bigger, BeyondSpring or TransCode Therapeutics?
TransCode Therapeutics (RNAZ) is larger, with a market capitalization of $29.29M compared with $25.08M for BeyondSpring (BYSI).
Which stock has performed better over the past year, BYSI or RNAZ?
BYSI returned -64.09% over the past 12 months, compared with -85.60% for RNAZ (price return, excluding dividends). Past performance does not predict future results.
Are BeyondSpring and TransCode Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.